The federal court of Canada on Monday dismissed a plea by drugmakers challenging the Canadian government's new regulations aimed at lowering prices of patented drugs that could potentially lead them to lose billions over a decade.
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann
The court struck down one part of the new regulation, finding that using certain payments to third parties to determine a drug’s regulated price went beyond the government’s authority, but upheld the bulk of the rules. The new rules will save money for patients, employers and insurers including the government at the expense of drug company profits.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead sets price for Covid-19 treatment as HHS secures dosesThat puts the price of a five-day treatment course at $2,340 per patient for people enrolled in federal health programs.
Read more »
Supreme Court turns away challenge to federal executions by lethal injectionThe Supreme Court turned away a major challenge to the federal government's lethal injection protocol on Monday, a win for the Trump administration that has set execution dates to begin mid-July after a nearly two-decade lapse.
Read more »
Supreme Court strikes down restrictive Louisiana abortion law that would have closed clinicsBreaking: Supreme Court strikes down restrictive Louisiana abortion law that would have closed clinics. Chief Justice John Roberts joined the court’s liberal justices in the ruling.
Read more »
Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patientThe price tag is below the $5,080 per course recommendation by U.S. drug pricing research group, the Institute for Clinical and Economic Review (ICER), last week. Remdesivir is at the forefront of the fight against COVID-19 after the anti-viral treatment helped shorten hospital recovery times in a clinical
Read more »
Gilead prices coronavirus drug remdesivir at $2,340 for five-day treatmentGilead says it will charge the U.S. government and other developed countries $2,340 for a typical course of remdesivir. The price will then rise.
Read more »